All coverage
Disputes leave AstraZeneca boss with chronic vaccine headache
By Sarah Neville, Hannah Kuchler & Donato Paolo Mancini
AstraZeneca counters Indonesian Muslim concerns over COVID-19 vaccine
By William Mallard, Nilufar Rizki & Fathin Ungku
Covid: AstraZeneca vaccine 79% effective with no increased blood clot risk – US trial
By Sarah Boseley
AstraZeneca may have included outdated information in Covid vaccine trial, U.S. health agency says
By Sam Meredith
AstraZeneca Vaccine 100% Effective In Preventing Severe Disease And Hospitalizations, U.S. Trials Show
By Siladitya Ray
U.S. Health Officials Question AstraZeneca Vaccine Trial Results (Published 2021)
By Benjamin Mueller, Rebecca Robbins & Sharon LaFraniere
AstraZeneca Got Its Vaccine Right. The Rollout Has Been a Mess.
By Joseph Walker, Jenny Strasburg & Thomas M. Burton
South Africa sells AstraZeneca COVID-19 vaccines to other African countries
By Olivia Kumwenda & Giles Elgood